Seven vaccines you need right now May 9, 2008
Hepatitis B vaccine: Recombivax HB or Engerix-B. Both vaccines protect against the hepatitis B virus, which is spread through sexual contact or contaminated needles and blood. (CNN -- Health)
FDA approves accelerated dosing schedule for Glaxosmithkline's Twinrix Apr 3, 2007
The FDA approved the new dosing schedule after reviewing the safety and immune response of Twinrix given to 250 healthy adults (aged 18 years or older) at 0-, 7-, and 21- to 30-day schedule, followed by a booster dose at 12 months, compared to separate vaccinations with monovalent hepatitis A vaccine (HAVRIX at 0 and 12 months) and hepatitis B vaccine (ENGERIX-B at 0, 1, 2, and 12 months) given to 246 healthy adults as a control group. The study demonstrated that the individuals who completed... (EurekAlert! -- Business News)
Dynavax Stock Rises After Positive Trial Nov 30, 2006
If it reaches market, Heplisav would have two competitors, Engerix-B from London-based GlaxoSmithKline PLC, and Recombivax from Whitehouse Station, N.J.-based Merck /p. Currently, GlaxoSmithKline rakes in about $450 million a year from its hepatitis B vaccine, while Merck takes in about $270 million, according to Pacific Growth analyst Katherine Xu. (ABC News -- Wire)
